Alaunos Therapeutics (TCRT) Cost of Revenue (2009 - 2011)
Alaunos Therapeutics' (TCRT) quarterly Cost of Revenue came in at $10.7 million in Q3 2011, up 86.78% YoY from $5.7 million in Q3 2010, and up 16.9% on a QoQ basis from $9.1 million in Q2 2011.
Alaunos Therapeutics (TCRT) Cost of Revenue (2009 - 2011) Analysis & Trends
Alaunos Therapeutics (TCRT) has 3 years of Cost of Revenue data on file, last reported at $10.7 million in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 93.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 174.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 298.26 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 387.98 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 67.21 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 10.67 Mn |
| Sep 30, 2011 | 10.67 Mn |
| Jun 30, 2011 | 9.13 Mn |
| Jun 30, 2011 | 9.13 Mn |
| Sep 30, 2010 | 5.71 Mn |
| Sep 30, 2010 | 5.71 Mn |
| Jun 30, 2010 | 2.22 Mn |
| Jun 30, 2010 | 2.22 Mn |
| Sep 30, 2009 | 1.23 Mn |
| Sep 30, 2009 | 1.23 Mn |